Back

The efficacy and safety of thrombolytic therapy for acute pulmonary embolism in patients with active malignant disease

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Treatment of acute pulmonary embolism across the strata risk Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Slobodan Obradovic

Military Medical Academy of Belgrade, School of Medicine, University of Defense, Belgrade (Serbia)

8 More presentations in this session

Presentation thumbnail
Comparison of ultrasound-assisted thrombolysis and mechanical thrombectomy in patients with intermediate-high-risk pulmonary embolism
Doctor D. Pinsdorf (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Trends in home treatment and early discharge of patients with low-risk pulmonary embolism.
Mr I. Farmakis (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Ultrasound assisted, catheter-directed thrombolysis for acute intermediate-high and high risk pulmonary embolism: focus on safety for oncological patients
Doctor C. Colombo (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Recent secular trends of catheter-directed therapy for treatment of pulmonary embolism: a retrospective cohort study based on German national data
Doctor V. Oettinger (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Right ventricular dysfunction parameters at echocardiography in patients with acute pulmonary embolism: meta-analysis of individual participant data
Doctor L. Cimini (Perugia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of acute pulmonary embolism across the strata risk

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Baseline characteristics, management patterns and outcome in patients with pulmonary embolism and malignancy: Insights from a single-centre study
thumbnail
Congress Presentation
Ultrasound assisted, catheter-directed thrombolysis for acute intermediate-high and high risk pulmonary embolism: focus on safety for oncological patients
thumbnail
Congress Presentation
Short and long-term mortality in patients with acute pulmonary embolism: focus on cancer-related disease.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources